These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 7594319

  • 1. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract] [Full Text] [Related]

  • 2. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA, van Etten RJ, Lai JY, Schneeberger PM, van de Wouw BA, Driessen WM.
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [Abstract] [Full Text] [Related]

  • 4. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW.
    Am J Health Syst Pharm; 1999 Dec 01; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [Abstract] [Full Text] [Related]

  • 5. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer.
    Yamamoto I, Fukuda Y, Okui M, Tamura K, Shimoyama T.
    J Clin Gastroenterol; 1995 Dec 01; 20 Suppl 1():S38-42. PubMed ID: 7673613
    [Abstract] [Full Text] [Related]

  • 6. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct 01; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 7. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K, Kato T, Sakagawa T.
    J Clin Gastroenterol; 1995 Oct 01; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA, Samsom M, Smout AJ.
    Aliment Pharmacol Ther; 2000 Jul 01; 14(7):961-2. PubMed ID: 10886054
    [No Abstract] [Full Text] [Related]

  • 9. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P, Simon B.
    Fortschr Med; 1996 Dec 20; 114(35-36):497-9. PubMed ID: 9119351
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA.
    Am J Health Syst Pharm; 1996 Jun 15; 53(12):1401-15. PubMed ID: 8781686
    [Abstract] [Full Text] [Related]

  • 11. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
    Hazell SL, Mitchell HM, Hanna G, Daskalopoulos G.
    Eur J Clin Microbiol Infect Dis; 1997 Jul 15; 16(7):530-2. PubMed ID: 9272389
    [Abstract] [Full Text] [Related]

  • 12. [Comparative study of proton pump inhibitors].
    Herszényi L, Tulassay Z.
    Orv Hetil; 2001 Sep 09; 142(36):1953-61. PubMed ID: 11680100
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N.
    Am J Gastroenterol; 2005 Nov 09; 100(11):2393-4. PubMed ID: 16279890
    [Abstract] [Full Text] [Related]

  • 14. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Nov 09; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 15. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R.
    Fortschr Med; 1994 Jan 20; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M, Saita H, Takahashi Y, Kusaka S, Asagoe K, Dekigai H, Matsumoto M, Seki M, Mizuno M, Maeda S.
    J Clin Gastroenterol; 1995 Jan 20; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [Abstract] [Full Text] [Related]

  • 17. [Polaprezinc].
    Kuwayama H, Takahashi M, Suzuki K, Suga M, Takata H, Ohara T, Koizumi K, Kiriyama Y.
    Nihon Rinsho; 2002 Feb 20; 60 Suppl 2():717-20. PubMed ID: 11979877
    [No Abstract] [Full Text] [Related]

  • 18. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T, Tejada M, Marchetti F, Favini P, Pizzarelli G, Campa M, Senesi S.
    J Antimicrob Chemother; 1998 Mar 20; 41 Suppl B():29-35. PubMed ID: 9579710
    [Abstract] [Full Text] [Related]

  • 19. Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication.
    Claessens AA, Heerdink ER, van Eijk JT, Lamers CB, Leufkens HG.
    Eur J Clin Pharmacol; 2000 Jan 20; 55(10):773-6. PubMed ID: 10663458
    [No Abstract] [Full Text] [Related]

  • 20. [Two step therapy for education of Helicobacter pylori].
    Matsukura N.
    Nihon Shokakibyo Gakkai Zasshi; 1997 Aug 20; 94(8):569. PubMed ID: 9284449
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.